denosumab

发音

UK /dɪˈnɒs.jʊ.mab/
US /dɛnˈoʊ.səˌmæb/
US /dəˈnɑs.jəˌmæb/

别名

denasumab

释义与例句

n.
  1. 1.

    A drug (trademarks Prolia and Xgera) that is a genetically engineered monoclonal antibody that reduces bone resorption and increases bone mass by inhibiting osteoclast formation and function and that is administered by injection to prevent fractures associated with osteoporosis and malignant tumors of bone and to treat hypercalcemia associated with various cancers.

    不可数 医学

词源

From arbitrary prefix den- + -os- (“bone”) + -umab (“human monoclonal antibody”).

来源：wiktionary